A. Kantar et al., OXATOMIDE ATTENUATES THE PRIMING CAPACITY ON POLYMORPHONUCLEAR LEUKOCYTES OF NASAL LAVAGE FLUID OBTAINED AFTER ALLERGEN CHALLENGE, Current therapeutic research, 59(6), 1998, pp. 395-405
Citations number
32
Categorie Soggetti
Pharmacology & Pharmacy","Medicine, Research & Experimental
The priming activity on polymorphonuclear leukocytes (PMLs) of nasal l
avage fluid obtained from children with seasonal allergic rhinitis aft
er specific allergic challenge, before and after a 14-day treatment pe
riod with orally administered oxatomide 12.5 mg twice daily, was inves
tigated by means of chemiluminescence. Luminol-amplified chemiluminesc
ence of PMLs activated with N-formyl-methionyl-leucyl-phenylalanine (f
MLP) or phorbol myristate acetate (PMA) was evaluated in the presence
or absence of nasal lavage fluid, A significant increase in the chemil
uminescence response of fMLP-stimulated PMLs was induced by nasal lava
ge fluid. No significant change was observed in PMA-stimulated PMLs. O
xatomide treatment significantly reduced the effect of nasal lavage fl
uid on PMLs, These data suggest a priming potency on PMLs of nasal lav
age fluid obtained from patients with seasonal allergic rhinitis after
specific challenge, probably because of the presence of various infla
mmatory mediators, Oxatomide treatment significantly reduced this prim
ing capacity.This effect may be attributed to the inhibition of cellul
ar recruitment or to the reduction of mediator release at the inflamma
tion site.